Biolife Solutions (BLFS) Cash from Investing Activities (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Cash from Investing Activities for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.
- Quarterly Cash from Investing Activities fell 98.46% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$71.5 million through Dec 2025, down 222.71% year-over-year, with the annual reading at -$71.5 million for FY2025, 222.71% down from the prior year.
- Cash from Investing Activities for Q4 2025 was $1.1 million at Biolife Solutions, up from -$6.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $73.6 million in Q4 2024, with the low at -$39.5 million in Q2 2025.
- Average Cash from Investing Activities over 5 years is -$3.3 million, with a median of -$2.4 million recorded in 2021.
- The sharpest move saw Cash from Investing Activities skyrocketed 1760.93% in 2024, then plummeted 12196.83% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$2.5 million in 2021, then tumbled by 485.92% to -$14.9 million in 2022, then skyrocketed by 126.57% to $4.0 million in 2023, then surged by 1760.93% to $73.6 million in 2024, then tumbled by 98.46% to $1.1 million in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at $1.1 million, -$6.0 million, and -$39.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.